NNK-32238-57980
3 vaccinations
4 coded responses
30 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 017 / MA
- Registered
- 2021-04-16
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Registered dependents
62P-86640-59020
Child or adolescent in my care · Male · 2022-07-07
6AZ-18692-30399
Child or adolescent in my care · Female · 2022-07-07
Timeline
-
2021-04-14
Dose 1 — Moderna
-
2021-04-16
Registered in v-safe
- 2021-04-18
- 2021-04-19
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
-
2021-05-19
Dose 2 — Moderna
- 2021-05-19
-
2021-05-20
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Decreased appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-22
- 2021-05-24
- 2021-05-26
- 2021-06-03
- 2021-06-09
- 2021-06-16
-
2021-06-23
Survey response — day 35, dose 2MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-30
Survey response — day 42, dose 2MedDRA: Eye pruritus, Nasal congestion, Pre-existing disease, Rhinorrhoea, Sneezing — Feeling: FairFree text: Allergies, sneezing, stuffy nose, runny nose, itchy eyesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-20
- 2021-11-19
-
2022-01-13
Dose 3 — Moderna
-
2022-01-13
Health check-in — day 0, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-14
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-15
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2022-01-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-22
- 2022-01-27
-
2022-02-05
Survey response — day 21, dose 3MedDRA: Dyspnoea, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Shortness of breath, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-02-17
- 2022-02-26
- 2022-04-16
- 2022-07-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-14 | Moderna | |
| 2 | 2021-05-19 | Moderna | |
| 3 | 2022-01-13 | Moderna | No |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Decreased appetite
Release 9 — day 35, dose 2
Symptoms: Sore throat
Release 9 — day 42, dose 2
Symptoms: Allergies, sneezing, stuffy nose, runny nose, itchy eyes
Release 11 — day 21, dose 3
Symptoms: Shortness of breath, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SD | Eye pruritus | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release